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Objective: Electrical stimulation can be applied in a variety
of ways to the hemiparetic upper extremity following stroke.
The aim of this review is to explore the relationship between
characteristics of stimulation and the effect of electrical
stimulation on the recovery of upper limb motor control
following stroke.
Methods: A systematic literature search was performed to
identify clinical trials evaluating the effect of electrical
stimulation on motor control. The reported outcomes were
examined to identify a possible relationship between the
reported effect and the following characteristics: duration of
stimulation, method of stimulation, setting of stimulation
parameters, target muscles and stage after stroke.
Results: Nineteen clinical trials were included, and the
results of 22 patient groups were evaluated. A positive effect
of electrical stimulation was reported for 13 patient groups.
Positive results were more common when electrical stimu-
lation was triggered by voluntary movement rather than
when non-triggered electrical stimulation was used. There
was no relation between the effect of electrical stimulation
and the other characteristics examined.
Conclusion: Triggered electrical stimulation may be more
effective than non-triggered electrical stimulation in facili-
tating upper extremity motor recovery following stroke. It
appears that the specific stimulus parameters may not be
crucial in determining the effect of electrical stimulation.
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INTRODUCTION
Upper extremity hemiparesis is a prominent impairment
following stroke and has significant impact on activities of
daily living (ADLs) and quality of life. Recovery of upper
extremity function is most rapid during the first months after
stroke (1, 2). However, even 3 months after stroke only 20%
of the stroke survivors have normal upper extremity function
(1). Accordingly, the majority of stroke survivors report that
impaired upper extremity function is a major problem (3) and
this is associated with a low level of subjective well-being (4).
There is growing evidence that electrical stimulation (ES) has
a positive effect on upper extremity motor recovery following
stroke (5–7). Therefore ES might be a useful therapy in the
rehabilitation of patients with stroke. However, published
reports demonstrate a wide variety of stimulation paradigms
with respect to stimulation parameters, method of stimulation
and duration of treatment. This raises the question of how ES
should be applied in daily practice.
Various devices are available for the application of ES, which
provide different possibilities for adjustment of stimulation
parameters including amplitude, pulse duration and pulse
frequency. These parameters determine the nature of the evoked
response and have impact on patient comfort and safety. ES at
low current intensity will evoke a sensory reaction without
muscle contraction (i.e. sensory stimulation). In motor stimu-
lation current intensity is high enough to exceed motor threshold
and evoke muscle contractions. Increasing current intensity
increases the force of muscle contraction (8), but also the risk of
pain and skin irritation.
Basic animal (9) and neurophysiological studies (10) as well
as clinical trials (11) suggest that afferent input associated with
repetitive movements facilitates improvement of motor func-
tion. For this reason it is hypothesized that motor stimulation is
more effective in improving motor control than is sensory
stimulation. Although there is no direct evidence, this is likely
since ES that provokes motor activation is associated with
cutaneous, muscle and joint proprioceptive afferent feedback,
while sensory ES is associated only with cutaneous afferents.
Therefore this review focused on motor stimulation.
With regard to motor stimulation, several methods of
application have been reported (7). In neuromuscular electrical
stimulation (NMES), the stimulation is applied according to
a pre-programmed scheme, resulting in repetitive muscle
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contractions without active involvement of the patient (6). In
EMG-triggered electrical stimulation (EMG-stim), ES is pro-
vided when volitionally generated EMG signals exceed a pre-set
threshold (6). In positional feedback stimulation training
(PFST), ES is provided when voluntary muscle contraction
produces joint translation beyond a pre-set threshold (12). Both
of these latter approaches reinforce voluntary muscle contrac-
tion. It is suggested that in EMG-stim and PFST the effect of ES
is maximized by adding a cognitive component (6, 12).
Transcutaneous electrical nerve stimulation (TENS) is well
known for the treatment of pain by evoking a sensory reaction
without muscle contraction. By adjusting the stimulation
parameters, muscle contractions can be evoked by TENS, which
is then effectively motor stimulation.
When studies investigating ES differ with respect to stimu-
lation parameters, method of stimulation and duration of the
treatment, the question is whether these differences have any
effect on therapeutic benefit. Therefore, the aim of the present
descriptive literature review is to explore the relationship
between several stimulation and clinical characteristics and
the effect of ES on motor control of the hemiparetic arm.
The characteristics under study are method of stimulation,
duration of stimulation, stimulation frequency, amplitude and
pulse duration, target muscles and stage after stroke. Motor
control is defined as the ability to perform voluntary move-
ments (13).
METHODS
Literature search
A systematic literature search from January 1966 to December 2003 was
performed in Medline, Embase and the database of the Cochrane Field
“Rehabilitation and Related Therapies” in order to identify clinical trials
in which ES was applied to improve motor control of the upper extremity
in stroke. The following key words were used: cerebrovascular
disorders, hemiplegia, hemiparesis, arm, upper extremity, electric
stimulation therapy, electric stimulation, neuromuscular electrical nerve
stimulation and transcutaneous electrical nerve stimulation. References
of literature were checked for relevant publications.
Selection criteria
Studies meeting the following criteria were included in the review:
 ES applied to the affected upper extremity in patients with stroke
 ES provoking muscle contraction
 application of ES with surface electrodes
 clinical setting, i.e. case series, case-control or randomized controlled
trial
 relevant outcome measures for motor control
 separate results presented for the upper extremity
 full-length publication in English, German, French or Dutch
The application of these criteria resulted in the exclusion of studies
that focused on invasive techniques, such as electro-acupuncture or
implanted electrodes. Studies in which ES was applied only to the
shoulder were excluded as well.
Data-extraction
For each selected study, stimulation as well as study characteristics were
extracted from the publication. Stimulation characteristics were:
 device applied
 method of stimulation
 target muscles
 duration of stimulation in hours per week and total hours
 specific setting for frequency, amplitude and pulse width. Investiga-
tors’ rationales for their particular setting were noted.
The study characteristics were:
 study design
 number of patients
 age and stage of the patients
 outcome measures
In the present review, the outcome measure considered most relevant
for motor control was selected for each trial. For this “primary” outcome
measure, the effect of ES, as reported by the author in the original
article, was assessed as positive ( p 0.05), or negative/no difference
( p 0.05). In this context outcome of between-group analysis was
assessed for studies with an acute or subacute population to account
for spontaneous recovery. However, for chronic patients the within-
group analysis was evaluated since spontaneous recovery was not
expected.
Statistics
The results were examined to identify a possible relationship between
the reported effect and the following characteristics: duration of
stimulation (analysed for hours per week and total hours), stimulation
method, frequency, amplitude, pulse width, target muscles and stage
after stroke. To test a possible relationship between effect and these
characteristics, univariate logistic regression analysis was applied for
continuous variables and the chi-square test for categorial variables
(SPSS 11.5 for Windows). For the analysis, method of stimulation was
dichotomized into triggered (EMG-stim and PFST) or non-triggered
(NMES, TENS and electroacupuncture) stimulation. Studies in which all
patients received triggered as well as non-triggered ES were excluded for
the analysis of method of stimulation. In the analysis of stimulation
frequency, studies with a broad frequency range were excluded and in
studies with a narrow range the mean of the limits was entered in the
analysis. Since the choice of the primary outcome measures by the
reviewers might bias the conclusion, an additional analysis was
performed with the results reported for grip strength or wrist extensor
strength.
RESULTS
Selection of literature
The literature search in the different databases yielded 156
articles altogether. Twenty publications, describing 19 trials,
fulfilled all selection criteria and were included in the present
review (12, 14–32, see Table I). In 6 trials 2 different methods of
ES were applied (15–17, 21, 26, 27). In 3 of these both ES
treatment groups were reviewed separately (21, 26, 27). In the
other 3, separate analysis of the different treatment groups was
not reported, and the overall result of the trial was included for
the review (15–17). In all, the results of 22 patient groups were
evaluated.
Of the 19 trials, 12 were randomized controlled trials (12,
14–25), 2 were non-randomized controlled trials (26, 27), 2
trials used a multiple baseline design (28, 29) and 3 trials were
case series (30–32).
Subjects
The review included a total of 578 stroke survivors with 392
receiving ES in one form or another. Four studies included
patients in the acute stage after stroke (i.e. within 1 month post-
stroke) (18, 19, 22, 25), 2 studies included subacute subjects
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(between 1 and 6 months post-stroke) (12, 29), 10 studies
included chronic subjects (6 months post-stroke) (14–17, 20,
21, 23, 26, 30, 32) and 3 studies included a mixed population
with respect to time since stroke (27, 28, 31).
With respect to stroke severity, 7 studies restricted inclusion
to patients with residual wrist extension (at least 5–20 degrees)
(12, 14–17, 19, 21). It can be assumed that the same is true for
the study described by Hummelsheim et al. (28), since EMG-
stim was applied, which by definition requires residual volitional
wrist extensor activity to trigger the stimulation. Inclusion
criteria with respect to stroke severity were not specified in 3
studies (25–27) and various criteria were applied in the other
studies. All studies were rather heterogeneous with respect to
stroke severity.
Characteristics of stimulation
Table II presents the stimulation characteristics retrieved from
the publications.
Method of stimulation. The method of stimulation varied
between the studies, and included NMES (n receiving
NMES = 157, n control = 51) (18, 21, 22, 26, 27, 29–32),
EMG-stim, (n receiving EMG-stim = 127, n control = 41)
(14–17, 19, 26–28), PFST (n receiving PFST = 15, n control =
15) (12) and TENS (n receiving TENS = 26, n control = 18)
(23, 24). The study by Wong et al. (25) described the effects
of electroacupuncture. However, since the acupuncture was
applied with surface electrodes, and not with needles, this study
was included in the review (n receiving acupuncture = 59, n
control = 59). In one study, patients received EMG-stim for
half of the treatment time and NMES for the other half (20).
Frequency. Most authors used fixed frequency, ranging from
20 Hz (22) to 50 Hz (14–17, 20). Some authors used a range of
frequency (18, 19, 25–29) and 2 of these adjusted frequency to
patient comfort (18, 19). Sonde et al. (23, 24) applied low-
frequency TENS with a stimulus frequency of 1.7 Hz in pulse
trains of 8 pulses with an interval of 14 ms.
Amplitude. Most authors reported a range for the amplitude.
However, it was not always clear whether the range represented
the overall range of the device or the range of amplitudes
actually used. Reported range varied from as wide as 0–100 mA
(31) to as narrow as 30–45 mA (12).
Pulse duration. Most studies used fixed pulse duration of 200 or
300 s. In 2 studies pulse duration was adjusted for optimal
contraction and patient comfort (21, 32). In 2 other studies pulse
duration was 500 s (28, 29).
Rationale for the particular setting applied. All but one study
(27) reported that amplitude was adjusted for optimal response,
which was “muscle contraction”, “wrist and finger movements”
or “full joint movement”. In 4 studies (18, 21, 31, 32) amplitude
was adjusted for patient comfort. None of the authors provided
rationale for the specific pulse duration or frequency, although
several reported that pulse duration (21, 32) and/or frequency
(18, 19) were adjusted for patient comfort. Apart from muscle
response and patient comfort no fundamental arguments were
presented for the specific setting of stimulation parameters.
Target muscles. A variety of muscles were stimulated. Fourteen
studies stimulated the wrist and/or finger extensor muscles (12,
14–23, 26, 27, 31). One of these also stimulated elbow extensors
(27), while another also included elbow extensors and shoulder
abductors (17). In 2 trials some patients received additional
stimulation of elbow extensors and/or shoulder muscles (23, 26).
Five studies stimulated both wrist/finger extensors and flexors
(21, 28–30, 32). In 2 trials, both arm and leg muscles were
stimulated, either simultaneously (25) or consecutively (27).
Duration of stimulation. Table II shows that there was a wide
range in duration of ES treatment: from 30 minutes once a day
(25) to 3 times 1 hour per day (21, 32), for a period of 2 weeks
(14–17, 25) to 3 months (23). None of the authors substantiated
their specific duration of stimulation treatment.
Relationship between treatment effect, and stimulation and
study characteristics
Table III shows the relationship between reported treatment
effect, and stimulation and study characteristics. There was a
relationship between treatment effect and method of stimulation.
Eight out of the 9 patient groups in which triggered stimulation
was applied yielded a positive result (88.9%), whereas only 4 out
of 12 groups using non-triggered stimulation yielded positive
results (33.3%). The ratio of these success rates is 2.7. The
difference in treatment effect with respect to method of
stimulation was significant (chi-square test, p = 0.024).
With respect to hours of stimulation per week, total hours of
stimulation and frequency of stimulation, univariate logistic
regression analysis did not reveal a difference between studies
with and without a positive effect. Stage after stroke did not
affect the effect of electrical stimulation (chi-square test).
The data in Table III might suggest an increased likelihood of
a positive effect if elbow and/or shoulder muscles were stimu-
lated in addition to wrist and/or finger extensors. However, in 2
studies (23, 26) it was not known how many subjects received
additional stimulation and in which muscles. If these studies are
excluded, there is insufficient number of studies that included
elbow and shoulder stimulation for analysis.
With respect to amplitude of stimulation, authors reported
wide ranges within each study and across studies (Table II).
Nearly all studies reported that amplitude was individually
adjusted to achieve muscle contraction or joint movement. This
strategy would undoubtedly lead to significant heterogeneity
within each study. However, as noted earlier, the actual
amplitudes used by subjects were not reported. In view of
heterogeneity within the studies and the uncertainty of what was
actually used, stimulation amplitude was not further analysed.
The majority of studies reporting on pulse duration used 200
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Table I. Clinical characteristics of included trials
Author Intervention n
Age (years)
Mean (SD or
range) Stage Time post-stroke Outcome measures
Randomized controlled trials
Bowman (12) E PFST E 15 no data subacute 3 weeks – 4 months isometric wrist extension:
C no additional C 15 in 30° flexion
therapy in 30° extension
aROM of wrist:
in patterned motion
in selective motion
Cauraugh (14) E EMG-stim E 7 61.64 (9.57) chronic 3.49 years (2.56) reaction time
C voluntary wrist ext. C 4 sustained contr. wrist ext
FM, MAS
box&block
Cauraugh (15) E1 EMG-stim/bilat E1 10 63.7 chronic 39.1 months box&block
E2 EMG-stim E2 10 reaction time
C voluntary wrist/
finger ext.
C 5 sustained contr. wrist ext
Cauraugh (16) EMG-stim/bilat E1 10 66.4 (9.7) chronic 2.8 years (1.9) box&block
E1 on time 10 E2 10 reaction time
seconds C 6 sustained contr. wrist ext
E2 on time 5 seconds
C on time 0 seconds
Cauraugh (17) E1 EMG-stim/block E1 14 E1 65.1 chronic E1 3.2 years box&block
E2 EMG- E2 14 E2 67.3 E2 3.3 years C 3.1 reaction time
stim/random C 6 C 65.8 years sustained contr. wrist ext
C voluntary
movements
Chae (18) E NMES E 14 E 59.4 (11.1) acute E 13.6 days (7.1) FM
C placebo stimulation C 14 C 60.0 (15.1) C 17.8 days (5.9) self-care FIM
Francisco (19) E EMG-stim E 4 E 60.3(15.6) acute E 17.5 days (2.4) FM
C additional therapy C 5 C 69.6(16.2) C 18.2 days (2.3) self-care FIM
Kimberley (20) E EMG- E 8 E 58.4 (14.5) chronic E 28.4 months isometric strength dig II
stimNMES C 8 C 62.8 (13.8) (18.7) Motor Activity Log
C sham stimulation C 38.5 months box&block
(30.7) Jebson Taylor
finger tracking
functional MRI
De Kroon (21) E1 NMES flex-ext E1 13 E1 58 (17.3) chronic E1 14.7 months Ashworth
E2 NMES ext only E2 15 E2 61.7 (9.7) (11.8) aROM
E2 21.4 months grip strength
(16.1) Motricity Index
Action Research Arm test
Powell (22) E NMES E 27 E 69.0 (10.8) acute E 23.9 days (7.7) resting wrist angle
C visits to C 28 C 66.4 (12.2) C 22.9 days (5.5) pROM, aROM
physiotherapist isometric wrist extension at
0°, 15° and 30°
modified Ashworth
grip strength
Action Research Arm test
9-hole peg test
VAS discomfort
star cancellation test
Rankin, Barthel
Sonde (23, 24) E TENS E 26 E 71 (6.0) chronic E 9.1 months (2.2) modified Ashworth
C no additional
therapy
C 18 C 73 (3.5) C 8.3 months (2.1) VAS spasticity
VAS shoulder pain
pROM, aROM
sensation
FM
Barthel
Wong (25) E electroacupuncture E 59 E 60.4 (11.1) acute 10–14 days Brunnstrom stage:
C no additional
therapy
C 59 C 60.6 (10.8) upper limb
lower limb
Chinese FIM
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or 300 s. In view of lack of heterogeneity across studies, pulse
duration was not further analysed.
DISCUSSION
Numerous studies have investigated the clinical effects of ES for
recovery of motor control after stroke. These studies reported a
variety of stimulation parameters, duration of stimulation,
subject characteristics and methods of stimulation. The present
review of these studies indicates that no relationship between the
specific setting of stimulation parameters, duration of stimu-
lation, subject characteristics, and clinical outcome could be
detected. However, it appears that triggered stimulation was
more likely to yield improvements in motor control than non-
triggered stimulation.
Specific stimulation parameters reviewed included frequency,
amplitude, and pulse duration. There was no relationship
between stimulation frequency and clinical outcome. Regarding
stimulus amplitude and pulse duration, no conclusions could be
drawn. However, in basic neurophysiological research the
setting of parameters does make a difference with respect to
reaction evoked by ES. Textbooks have indicated that careful
selection of parameters makes it possible to selectively activate
large diameter afferent fibres or motoneurones, at least in the
laboratory setting with isolated nerve preparation (8, 33). In
addition, different combinations of parameters (pulse duration
of 50 s vs 200 s, stimulation frequency of 4 Hz vs 110 Hz)
Author Intervention n
Age (years)
Mean (SD or
range) Stage Time post-stroke Outcome measures
Controlled trials
Kraft (26) E1 EMG-stim E1 6 E1 59.5 (6.2) chronic E1 26 months (23.4) FM
E2 NMES act E2 4 E2 64.8 (11.6) E2 36.8 months grip strength
E3 PNF E3 3 E3 67.0 (3.6) (19.8) Jebsen-Taylor
C no additional C 5 C 63.2 (12.3) E3 14.3 months (2.5) finger tapping
therapy C 24.2 months (6.0)
Mokrusch (27) E1 EMG-stim E1 22 59.8 (8.3) mixed 6 weeks (1–9 weeks) modified Ashworth
E2 NMES E2 12 3 chronic patients pendulum test
C no additional C 10 hand extension (myometer)
therapy Barthel, FIM
well being
Multiple baseline design
Hummelsheim
(28)
baseline-EMG-stim-
repetitive
movements
20 59 (32–91) mixed mean 16.5 weeks
(4 weeks –
24 months)
grip strength
isometric hand extension
isotonic hand extension
RMA (arm section)
modified Ashworth
Hummelsheim
(29)
baseline-NMES-
repetitive
movements
12 59.5 (41–80) subacute mean 7.6 weeks
(3 weeks –
4 months)
grip strength
isometric hand extension
isotonic hand extension
RMA (arm section)
modified Ashworth
Case series
Alon (30) NMES 29 61 (13.2) chronic 4.0 years
(SD 3.5; range
0.75–13)
grip strength
FM (subtest spherical grasp)
distance handpalm–finger
VAS pain upper limb
3 ADL tasks
grasp and hold weight
Baker (31) NMES 16 range 36–78 mixed 9 subacute 4 months
7 chronic 4 months
sensation
spasticity (4-point scale)
pROM
isometric wrist extension
Hendricks (32) NMES 15 52.8 (20–70) chronic 4.9 years
(0.75–18 years)
modified Ashworth
FM
aROM = active range of motion; C = control group; contr = contraction; dig = digiti; E = experimental group; EMG-stim = EMG-triggered
electrical stimulation; EMG-stim/bilat = treatment in which subjects received EMG-stim and assistance from unimpaired hand as wrist/finger
extension was executed on both limbs; ext = extension or extensor muscles; EMG-stim/block = 10 consecutive movement trials for each
muscle group; EMG-stim/random = random order of movement trials; FIM = Functional Independence Measure; flex = flexor muscles;
FM = Fugl Meyer motor assessment; MAS = motor assessment scale; n = number of subjects that completed treatment protocol;
NMES = neuromuscular electrical stimulation; PFST = positional feedback stimulation therapy; PNF = proprioceptive neuromuscular
facilitation; pROM = passive range of motion; RMA = Rivermead Motor Assessment; self-care FIM = self-care components of Functional
Independence Measure; TENS = transcutaneous electrical nerve stimulation; VAS = visual analogue scale.
  Continued
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have been reported to yield different peripheral neurophysio-
logical effects in the human superficial radial nerve (34). And
it has also been reported that low frequency stimulation (3 Hz)
induces prolonged depression of cortical excitability, while
high frequency (30 Hz) induces prolonged facilitation (35).
Given the aforementioned implications of parameter setting for
neurophysiological reaction, one might expect that differ-
ent neurophysiological reactions were evoked in the studies
included for this review. However, there were no indications
that different neurophysiological reactions were associated with
differences in clinical outcome. The common end point in all
studies was muscle contraction, despite the differences in
parameter setting. From this it is hypothesized that muscle
contraction is crucial in the effect of ES, rather than stimulus
parameters.
Muscle contraction also seemed to be the primary intent of
most investigators of the studies in this review, as amplitude
was adjusted to obtain an optimal motor response. Although
not explicitly stated by all authors, their goal appeared to be
the maximizing of muscle and joint afferent feedback via
ES mediated repetitive movement therapy to facilitate motor
recovery. This is consistent with the hypothesis of Asanuma &
Keller (10), that afferent feedback associated with repetitive
movements induces LTP in the motor cortex, which then
modifies the excitability of specific motor neurones and
facilitates motor learning.
Another common consideration for selection of specific
stimulation parameters was subject comfort. Studies relating
comfort and pulse duration reveal a preference for pulses of
300 s over 50 or 1000 s (36, 37). Most studies reporting on
pulse duration used 200 or 300 s. Increasing amplitude beyond
motor threshold not only excites motor neurones, but also small
diameter unmyelinated C fibres that elicit painful sensations
when stimulated. High amplitude stimulation will therefore
be uncomfortable for the patient (8). Most studies adjusted
amplitude to produce muscle contraction or joint translation
without subject discomfort. For motor stimulation textbooks
advise a tetanized contraction, which is usually achieved at
a stimulation frequency of 30–35 Hz (8, 38). Frequencies
markedly higher than this can cause rapid muscle fatigue and
also affect patient comfort (8, 38, 39). However, none of the
studies included in this review assessed patient comfort. There-
fore it was not possible to draw conclusions with regard to a
possible relation between stimulation parameters and subject
comfort, or to formulate more specific recommendations for
stimulation parameters to minimize discomfort.
There was no relationship between duration of stimulation
and effect. Stimulation as little as 2.5 hours per week was
enough to obtain a positive effect in 1 study (25), but stimulation
as much as 21 hours per week was not enough to guarantee an
effect in another (21). In contrast to expectations (40, 41), the
likelihood of a positive effect did not increase with increasing
intensity (hours per week) or total dose (total hours) of
stimulation. This may be an artefact of our methodology. The
treatment outcome in this review was dichotomized to either
“positive” or “no effect”. Due to heterogeneity of studies, the
extent of improvement was not taken into consideration. Thus, it
is possible that among studies with a “positive” effect, a dose-
response relationship exists.
This review did not detect a relationship between subject
characteristics and outcome of ES. Positive results were
obtained in studies that exclusively evaluated acute, subacute
and chronic subjects. Thus, positive results were reported
regardless of acuity. Previous subgroup analyses suggested
better outcomes among those with less severe hemiparesis (22,
23, 32). However, due to heterogeneity of severity of hemi-
paresis, the present review could not elucidate a correlation
between stroke severity and outcome. Among the studies there
was heterogeneity of target muscles. There might be an
indication that stimulation of elbow and shoulder muscles in
addition to finger and wrist extensor muscles promotes a positive
effect of stimulation, but the subgroups were considered too
small to draw reliable conclusions on this aspect of ES.
The one positive relation that emerged from the review is that
triggered stimulation may be more effective than non-triggered
stimulation in producing improvements in motor control.
Although both methods of ES provide muscle and joint
proprioceptive feedback, triggered stimulation adds a cognitive
component. Thus, afferent feedback associated with ES
mediated muscle contraction and joint translation is time locked
to subject cognitive intent. Animal studies have demonstrated
that specific types of behavioural experiences that induce long-
term plasticity on motor maps appear to be limited to those that
entail the development of new motor skills (42). When monkeys
were trained to retrieve food pellets from a small well (9, 43, 44)
or rats were trained to retrieve food from a rotating well (45)
there was evidence of task-specific cortical reorganization.
However, repetitive movement tasks that did not require skill
acquisition (i.e. automatic) were not associated with any
significant changes in motor cortex (44, 45). From a clinical
perspective, the behavioural experiences that induce long-term
plasticity in humans are likely to be those activities that are
important and meaningful, and require cognitive investment and
effort. Given this perspective, repetitive movement therapy
where the subject is cognitively involved in generating the
movement (i.e. triggered ES) is more likely to be important and
meaningful than therapy where the subject is not cognitively
involved (i.e. non-triggered ES). However, since none of the
studies directly compared methods in a randomized controlled
trial, there is no evidence that triggered ES is indeed more
effective than non-triggered ES.
This review was not able to detect a relationship between
stimulation parameters, duration of stimulation and subject
characteristics, and clinical outcome. However, the inability to
detect a relationship does not mean that a clinically relevant
relationship does not exist. The significant heterogeneity of
subjects, both within and across groups likely contributed
numerous confounding variables and possibly diluted relation-
ships that might otherwise be apparent. Due to the heterogeneity
of the studies, clinical outcome was dichotomized, as noted
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above, and this further reduced the amount of information
available for analysis and the likelihood that a relationship
could be detected. The review results might also be biased by
the choice of the primary outcome measures. Since the focus
was motor control, measures that assess movement broadly,
such as Fugl-Meyer Motor Assessment, Rivermead Mobility
Assessment and Motricity Index were preferred over isometric
wrist extensor strength and grip strength. Nevertheless, post hoc
analysis focussing on grip strength and wrist extensor strength
yielded similar results, thereby making the conclusion that
triggered ES might be more effective than non-triggered ES
more robust.
The questions posed in this review can only be addressed
fully by directly testing them in clinical trials. Future trials
should compare EMG-stim and non-triggered ES. It should be
investigated whether it is beneficial or not to apply ES to elbow
and shoulder muscles in addition to wrist and finger extensors.
Dose response trials should determine the optimal dose for ES.
With respect to stimulation frequency, amplitude and pulse
duration, a theoretical framework as to how these parameters
might influence clinical outcome should be formulated prior to
testing in clinical trials. The more important factor might be
muscle activation and joint translation rather than stimulus
parameters; the elucidation of the mechanism of action of ES
should be subject of future studies. The determination of optimal
clinical characteristics for ES treatment is challenging and
important, but difficult due to multiple confounding variables.
Finally, future studies should further document clinical rele-
vance and should preferably use a common core set of outcome
measures. The present review focussed on motor control.
Improvements in motor control should translate to improve-
ments in activities of daily living, and this aspect of ES should be
evaluated in future trials.
In conclusion, it appears that triggered or volitionally
activated ES is more likely to yield improvements in motor
control than non-triggered ES. In this review, no relationship
between stimulus parameters, duration of treatment, subject
characteristics, and clinical outcome could be detected. Future
clinical trials should determine the most appropriate method of
stimulation, optimal prescriptive parameters, clinical indications
and effect of ES at the level of activities of daily living.
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